Correlation Between Eliem Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Neurobo Pharmaceuticals
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Eliem and Neurobo is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.08 times more return on investment than Neurobo Pharmaceuticals. However, Eliem Therapeutics is 1.08 times more volatile than Neurobo Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 253.00 in Eliem Therapeutics on August 30, 2024 and sell it today you would earn a total of 51.00 from holding Eliem Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 99.8% |
| Values | Daily Returns |
Eliem Therapeutics vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Neurobo Pharmaceuticals |
Eliem Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |